Literature DB >> 7726327

Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.

L Frost, S Lal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7726327     DOI： 10.1176/ajp.152.5.810a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  10 in total

1.  Recent news about drug risks: application to Canadians.

Authors:  V Hogan; C Turner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

2.  Discontinuation reactions associated with SSRIs.

Authors:  L Macdonald
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 3.  ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Authors:  Linda Härmark; Florence van Hunsel; Birgitta Grundmark
Journal:  Drug Saf       Date:  2015-04       Impact factor: 5.606

Review 4.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

5.  Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

Authors:  Filippo Bogetto; Silvio Bellino; Raffaele Bonatto Revello; Luca Patria
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.

Authors:  K Black; C Shea; S Dursun; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

7.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

8.  Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

Authors:  Linda Härmark; June Raine; Hubert Leufkens; I Ralph Edwards; Ugo Moretti; Viola Macolic Sarinic; Agnes Kant
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

9.  Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.

Authors:  Linda Härmark; Eugène van Puijenbroek; Kees van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2012-06-12       Impact factor: 2.953

Review 10.  Antidepressant discontinuation syndromes.

Authors:  P M Haddad
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.